TWI800754B - Combination of gene marker and use thereof - Google Patents
Combination of gene marker and use thereof Download PDFInfo
- Publication number
- TWI800754B TWI800754B TW109134190A TW109134190A TWI800754B TW I800754 B TWI800754 B TW I800754B TW 109134190 A TW109134190 A TW 109134190A TW 109134190 A TW109134190 A TW 109134190A TW I800754 B TWI800754 B TW I800754B
- Authority
- TW
- Taiwan
- Prior art keywords
- combination
- gene marker
- marker
- gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010494278.4A CN111705130B (en) | 2020-06-03 | 2020-06-03 | Gene marker combination and application thereof |
CN202010494278.4 | 2020-06-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202146663A TW202146663A (en) | 2021-12-16 |
TWI800754B true TWI800754B (en) | 2023-05-01 |
Family
ID=72538593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW109134190A TWI800754B (en) | 2020-06-03 | 2020-09-30 | Combination of gene marker and use thereof |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN111705130B (en) |
TW (1) | TWI800754B (en) |
WO (1) | WO2021243906A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111705130B (en) * | 2020-06-03 | 2022-07-12 | 广州康立明生物科技股份有限公司 | Gene marker combination and application thereof |
CN111662980A (en) * | 2020-06-03 | 2020-09-15 | 广州市康立明生物科技有限责任公司 | Lung cancer detection reagent and kit |
CN111647657B (en) * | 2020-06-03 | 2022-07-12 | 广州康立明生物科技股份有限公司 | Lung cancer detection reagent and kit |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106232833A (en) * | 2014-01-30 | 2016-12-14 | 加利福尼亚大学董事会 | The haplotyping that methylates (MONOD) for non-invasive diagnostic |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011091270A2 (en) * | 2010-01-21 | 2011-07-28 | The Regents Of The University Of Michigan | Biomarkers for lung disease monitoring |
CN103627814B (en) * | 2013-12-13 | 2015-05-27 | 青岛大学医学院附属医院 | Reagent for detecting Notch signal path as well as PCR (Polymerase Chain Reaction) detecting method and application thereof |
JP6395131B2 (en) * | 2014-07-10 | 2018-09-26 | シスメックス株式会社 | Method for acquiring information on lung cancer, and marker and kit for acquiring information on lung cancer |
WO2016069461A1 (en) * | 2014-10-27 | 2016-05-06 | The Trustees Of The University Of Pennsylvania | A parkinson's disease diagnostic biomarker panel |
US11260387B2 (en) * | 2016-12-12 | 2022-03-01 | Cepheid | Integrated purification and measurement of DNA methylation and co-measurement of mutations and/or mRNA expression levels in an automated reaction cartridge |
CN110964810B (en) * | 2018-09-29 | 2022-04-29 | 广州康立明生物科技股份有限公司 | Application of HOXA7 and HOXA9 methylation detection reagent in preparation of lung cancer diagnostic reagent |
CN110964809B (en) * | 2018-09-29 | 2021-10-22 | 广州康立明生物科技股份有限公司 | HOXA7 methylation detection reagent |
CN110964813B (en) * | 2018-09-29 | 2021-11-16 | 广州康立明生物科技股份有限公司 | Application of HOXA7 methylation detection reagent in preparation of lung cancer diagnosis reagent |
CN110964812B (en) * | 2018-09-29 | 2021-10-22 | 广州康立明生物科技股份有限公司 | Application of HOXA9 methylation detection reagent in preparation of lung cancer diagnosis reagent |
CN110317875B (en) * | 2019-07-30 | 2024-06-21 | 苏州呼呼健康科技有限公司 | Methylation gene related to lung cancer and detection kit thereof |
CN111705130B (en) * | 2020-06-03 | 2022-07-12 | 广州康立明生物科技股份有限公司 | Gene marker combination and application thereof |
-
2020
- 2020-06-03 CN CN202010494278.4A patent/CN111705130B/en active Active
- 2020-09-29 WO PCT/CN2020/119001 patent/WO2021243906A1/en active Application Filing
- 2020-09-30 TW TW109134190A patent/TWI800754B/en active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106232833A (en) * | 2014-01-30 | 2016-12-14 | 加利福尼亚大学董事会 | The haplotyping that methylates (MONOD) for non-invasive diagnostic |
Non-Patent Citations (2)
Title |
---|
期刊 Daugaard, Iben, et al. "Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma." Scientific reports 6.1 (2016) , p 1-11. |
期刊 O’Mara, Tracy A., et al. "Analysis of promoter-associated chromatin interactions reveals biologically relevant candidate target genes at endometrial cancer risk loci." Cancers 11, 1440 2019 p 1-14.;期刊 Daugaard, Iben, et al. "Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma." Scientific reports 6.1 (2016) , p 1-11. * |
Also Published As
Publication number | Publication date |
---|---|
CN111705130A (en) | 2020-09-25 |
CN111705130B (en) | 2022-07-12 |
TW202146663A (en) | 2021-12-16 |
WO2021243906A1 (en) | 2021-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI800754B (en) | Combination of gene marker and use thereof | |
EP4022059A4 (en) | Oligonucleotide compositions and methods of use thereof | |
EP3959318A4 (en) | Oligonucleotide compositions and methods of use thereof | |
EP3965780A4 (en) | Oligonucleotide compositions and methods of use thereof | |
EP4037695A4 (en) | Oligonucleotide compositions and methods of use thereof | |
EP3775203A4 (en) | Oligonucleotide compositions and methods of use thereof | |
EP4143196A4 (en) | PI3K-a INHIBITORS AND METHODS OF USE THEREOF | |
EP4045643A4 (en) | Variants of cas12a nucleases and methods of making and use thereof | |
EP3962479A4 (en) | Kcnt1 inhibitors and methods of use | |
EP3983386A4 (en) | Acss2 inhibitors and methods of use thereof | |
EP3962481A4 (en) | Kcnt1 inhibitors and methods of use | |
EP3941475A4 (en) | Pyridazinones and methods of use thereof | |
EP3986894A4 (en) | Ectonucleotidase inhibitors and methods of use thereof | |
EP3998354A4 (en) | Genetic marker combination and application thereof | |
EP4090752A4 (en) | Plakophillin-2 gene therapy methods and compositions | |
EP4039676A4 (en) | Compound for inducing expression of anti-aging gene klotho and use thereof | |
EP4081231A4 (en) | Compositions comprising microbes and methods of use and making thereof | |
EP4048298A4 (en) | Preparation and use of therapeutic hydrogels | |
EP3941515A4 (en) | Targeted active gene editing agent and methods of use | |
EP3816282A4 (en) | Enzymes of luciferin biosynthesis and use thereof | |
EP3909063A4 (en) | Multiplexed assay and methods of use thereof | |
EP4037715A4 (en) | Protein-macromolecule conjugates and methods of use thereof | |
EP4142740A4 (en) | Compositions and methods of use thereof | |
EP3959197A4 (en) | Papd5 inhibitors and methods of use thereof | |
EP3950961A4 (en) | Application of kdm5a gene and atrx gene |